- Seismic raises $121M to enter immunology space spotlighted by argenx, Immunovant and others
- AbbVie’s new AI deal; Roche’s PhIII win in breast cancer; SpringWorks to raise $275M
- Bristol Myers’ lead deal negotiator to depart after inking series of multibillion-dollar acquisitions
- Now Meta Quest Pro Data Collection Features Allow Creating Scientific VR Research Apps in Python
- SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability
- STAT+: Key takeaways from AdvaMed, the world’s largest medical device conference
- Alzheon to Present ALZ-801 (Valiltramiprosate) Oral Tablet Program Update as Potential Treatment for Alzheimer’s Disease in Adults with Down Syndrome at 4th International Trisomy 21 Research Conference
- Patient death in Amgen’s mid-stage tarlatamab trial casts dark shadow over positive efficacy data: #ESMO23
- How Bristol Myers’ buyout offer for Mirati dwindled by billions of dollars
- AstraZeneca inks $247M deal with generative AI shop Absci to develop antibody drug for cancer